Medgend Icon







discontinued


Anastrozole FDA Approved Drugs

AFINITOR [EverolimusC53H83NO14]
RX
-
10mg (oral tablet)
2.5mg (oral tablet)
7.5mg (oral tablet)
NovartisMar 30, 2009
  • Treatment of advanced hormone receptor positive, her2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
  • Treatment of patients with progessive neuroendocrine tumors of pancreatic origin (pnet) that are unresectable, locally advanced or metastatic.
  • Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..
  • Treatment of solid excretory system tumors; advanced renal cell carcinoma (rcc), after failure of treatment with sunitinib or sorafenib.
efficacy
2.0  (2)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ANASTROZOLE [AnastrozoleC17H19N5]
RX
-
1mg (oral tablet)
Accord HlthcareJun 28, 2010
Apotex IncMay 11, 2012
Cipla LtdJun 28, 2010
Dr Reddys Labs LtdJun 28, 2010
Fresenius Kabi OncolJun 28, 2010
MylanJun 28, 2010
Natco Pharma LtdJun 28, 2010
Santos BiotechJun 28, 2010
Sun Pharm Inds LtdJul 15, 2011
Teva PharmsJun 28, 2010
West-ward Pharms IntJun 28, 2010
Zydus Pharms Usa IncJun 28, 2010
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ARIMIDEX [AnastrozoleC17H19N5]
RX
-
1mg (oral tablet)
Astrazeneca PharmsDec 27, 1995
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.